Prime Medicine prices $125M stock offering at $3.50/share
AI Summary
Prime Medicine priced a $125 million stock offering at $3.50 per share. The transaction will raise capital for the biotechnology company through an equity issuance.
Prime Medicine priced a $125 million stock offering at $3.50 per share. The transaction will raise capital for the biotechnology company through an equity issuance.
Seeking Alpha —
The Sydney Morning Herald —
Oilprice.com —
Seeking Alpha —
Seeking Alpha —
Seeking Alpha —